Nanocarrier-mediated inhibition of macrophage migration inhibitory factor attenuates secondary injury after spinal cord injury.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  ACS Nano

• Publication date

  2015-01-28

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1021/nn505980zPMID 25587936
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Macrophage Migration Inhibitory Factor (MIF): A Glucocorticoid Counter-Regulator within the Immune System.

  2017cited by this paper
• Large-Scale Chondroitin Sulfate Proteoglycan Digestion with Chondroitinase Gene Therapy Leads to Reduced Pathology and Modulates Macrophage Phenotype following Spinal Cord Contusion Injury

  2014cited by this paper
• The M1 and M2 paradigm of macrophage activation: time for reassessment

  2014cited by this paper
• Cytokine pathways regulating glial and leukocyte function after spinal cord and peripheral nerve injury.

  2014cited by this paper
• Apamin-mediated actively targeted drug delivery for treatment of spinal cord injury: more than just a concept.

  2014cited by this paper
• Toll-like receptor 2-mediated alternative activation of microglia is protective after spinal cord injury.

  2014cited by this paper
• Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies

  2014cited by this paper
• TNF and increased intracellular iron alter macrophage polarization to a detrimental M1 phenotype in the injured spinal cord.

  2014cited by this paper
• IL-4 Signaling Drives a Unique Arginase+/IL-1β+ Microglia Phenotype and Recruits Macrophages to the Inflammatory CNS: Consequences of Age-Related Deficits in IL-4Rα after Traumatic Spinal Cord Injury

  2014cited by this paper
• The antinociceptive effects of intracerebroventricular administration of Chicago sky blue 6B, a vesicular glutamate transporter inhibitor

  2013cited by this paper
• Macrophage Migration Inhibitory Factor Potentiates Autoimmune-Mediated Neuroinflammation

  2013cited by this paper
• The impact of chronic blood-brain barrier breach on intracortical electrode function.

  2013cited by this paper
• The Adenosine-Dependent Angiogenic Switch of Macrophages to an M2-Like Phenotype is Independent of Interleukin-4 Receptor Alpha (IL-4Rα) Signaling

  2013cited by this paper
• Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology.

  2013cited by this paper
• Macrophage plasticity and polarization in tissue repair and remodelling

  2013cited by this paper
• Nanomedicine for treating spinal cord injury.

  2013cited by this paper
• Selective nanovector mediated treatment of activated proinflammatory microglia/macrophages in spinal cord injury.

  2013cited by this paper
• M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination

  2013cited by this paper
• Chicago sky blue 6B, a vesicular glutamate transporters inhibitor, attenuates methamphetamine-induced hyperactivity and behavioral sensitization in mice.

  2013cited by this paper
• Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus.

  2013cited by this paper
• Pilot study: elevated circulating levels of the proinflammatory cytokine macrophage migration inhibitory factor in patients with chronic spinal cord injury.

  2013cited by this paper
• Nanoparticle-based evaluation of blood–brain barrier leakage during the foreign body response

  2013cited by this paper
• Microglial inhibitory factor (MIF/TKP) mitigates secondary damage following spinal cord injury.

  2012cited by this paper
• The Use of Methylprednisolone in Acute Spinal Cord Injury: A Review of the Evidence, Controversies, and Recommendations

  2012cited by this paper
• A Novel Allosteric Inhibitor of Macrophage Migration Inhibitory Factor (MIF)*

  2012cited by this paper
• IκBα deficiency in brain leads to elevated basal neuroinflammation and attenuated response following traumatic brain injury: implications for functional recovery

  2012cited by this paper
• Macrophage migration inhibitory factor (MIF) is essential for inflammatory and neuropathic pain and enhances pain in response to stress

  2012cited by this paper
• Mechanical Characterization of the Injured Spinal Cord after Lateral Spinal Hemisection Injury in the Rat

  2012cited by this paper
• Anti-Invasive Adjuvant Therapy with Imipramine Blue Enhances Chemotherapeutic Efficacy Against Glioma

  2012cited by this paper
• The upregulation of specific interleukin (IL) receptor antagonists and paradoxical enhancement of neuronal apoptosis due to electrode induced strain and brain micromotion.

  2012cited by this paper
• Macrophage Migration Inhibitory Factor Promotes Cell Death and Aggravates Neurologic Deficits after Experimental Stroke

  2011cited by this paper
• Antioxidant Therapies for Acute Spinal Cord Injury

  2011cited by this paper
• Spinal cord injury therapies in humans: an overview of current clinical trials and their potential effects on intrinsic CNS macrophages

  2011cited by this paper
• Repertoire of microglial and macrophage responses after spinal cord injury

  2011cited by this paper
• Wound macrophages as key regulators of repair: origin, phenotype, and function.

  2011cited by this paper
• MIF: a key player in cutaneous biology and wound healing

  2011cited by this paper
• Raman spectroscopic investigation of spinal cord injury in a rat model.

  2011cited by this paper
• Rescuing vasculature with intravenous angiopoietin-1 and alpha v beta 3 integrin peptide is protective after spinal cord injury.

  2010cited by this paper
• A small‐molecule inhibitor of macrophage migration inhibitory factor for the treatment of inflammatory disease

  2010cited by this paper
• NF-kappaB inhibition leads to increased synthesis and secretion of MIF in human CD4+ T cells.

  2009cited by this paper
• Identification of Two Distinct Macrophage Subsets with Divergent Effects Causing either Neurotoxicity or Regeneration in the Injured Mouse Spinal Cord

  2009cited by this paper
• Infiltrating Blood-Derived Macrophages Are Vital Cells Playing an Anti-inflammatory Role in Recovery from Spinal Cord Injury in Mice

  2009cited by this paper
• Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors.

  2009cited by this paper
• Deletion of macrophage migration inhibitory factor attenuates neuronal death and promotes functional recovery after compression-induced spinal cord injury in mice

  2009cited by this paper
• Nanoparticle-mediated local delivery of Methylprednisolone after spinal cord injury.

  2009cited by this paper
• Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury.

  2008cited by this paper
• Bone Marrow-Derived Macrophages (BMM): Isolation and Applications.

  2008cited by this paper
• Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP

  2008cited by this paper
• Spatial distribution and acute anti-inflammatory effects of Methylprednisolone after sustained local delivery to the contused spinal cord.

  2008cited by this paper
• Early Acute Management in Adults With Spinal Cord Injury: A Clinical Practice Guideline for Health-Care Providers. Who Should Read It?

  2008cited by this paper
• Nanoparticle therapeutics: an emerging treatment modality for cancer

  2008cited by this paper
• Nanocarriers as an emerging platform for cancer therapy.

  2007cited by this paper
• Toll‐like receptor (TLR)‐2 and TLR‐4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury

  2007cited by this paper
• Enabling Coupled Quantitative Genomics and Proteomics Analyses from Rat Spinal Cord Samples*S

  2007cited by this paper
• Delayed neuronal death after brain trauma involves p53-dependent inhibition of NF-κB transcriptional activity

  2007cited by this paper
• ImageJ for microscopy.

  2007cited by this paper
• A liposomal nanoscale contrast agent for preclinical CT in mice.

  2006cited by this paper
• Long‐circulating liposomal contrast agents for magnetic resonance imaging

  2006cited by this paper
• MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis

  2006cited by this paper
• Roles for NF-kappaB in nerve cell survival, plasticity, and disease.

  2006cited by this paper
• Degenerative and Spontaneous Regenerative Processes after Spinal Cord Injury

  2006cited by this paper
• The Timing of Surgical Intervention in the Treatment of Spinal Cord Injury: A Systematic Review of Recent Clinical Evidence

  2006cited by this paper
• Roles for NF-κB in nerve cell survival, plasticity, and disease

  2006cited by this paper
• Macrophages Sequentially Change Their Functional Phenotype in Response to Changes in Microenvironmental Influences1

  2005cited by this paper
• ISO-1 Binding to the Tautomerase Active Site of MIF Inhibits Its Pro-inflammatory Activity and Increases Survival in Severe Sepsis*

  2005cited by this paper
• Up-regulation of macrophage migration-inhibitory factor expression after compression-induced spinal cord injury in rats

  2004cited by this paper
• Regeneration beyond the glial scar

  2004cited by this paper
• Macrophage migration inhibitory factor: a regulator of innate immunity

  2003cited by this paper
• Post-traumatic inflammation following spinal cord injury

  2003cited by this paper
• Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis.

  2003cited by this paper
• Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties.

  2003cited by this paper
• Experimental Modeling of Spinal Cord Injury: Characterization of a Force-Defined Injury Device

  2003cited by this paper
• Matrix Metalloproteinases Limit Functional Recovery after Spinal Cord Injury by Modulation of Early Vascular Events

  2002cited by this paper
• Treatment of spinal cord impact injury in the rat with transforming growth factor-beta.

  2002cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite.

  2001cited by this paper
• Dynamic contrast‐enhanced MRI of experimental spinal cord injury: In vivo serial studies

  2001cited by this paper
• Spinal cord injury-induced inflammation: a dual-edged sword.

  2000cited by this paper
• The glial scar and central nervous system repair.

  1999cited by this paper
• INFLAMMATION, AUTOIMMUNITY AND SPINAL CORD INJURY.: 4

  1999cited by this paper
• Effects of pro-inflammatory cytokines in experimental spinal cord injury.

  1997cited by this paper
• A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability.

  1997cited by this paper
• Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study.

  1997cited by this paper
• Cellular inflammatory response after spinal cord injury in sprague‐dawley and lewis rats

  1997cited by this paper
• Administration of Methylprednisolone for 24 or 48 Hours or Tirilazad Mesylate for 48 Hours in the Treatment of Acute Spinal Cord Injury Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial

  1997cited by this paper
• Macrophage migration inhibitory factor (MIF): a glucocorticoid counter-regulator within the immune system.

  1997cited by this paper
• A quantitative spatial analysis of the blood-spinal cord barrier. I. Permeability changes after experimental spinal contusion injury.

  1996cited by this paper
• Transforming growth factor-beta stimulates arginase activity in macrophages. Implications for the regulation of macrophage cytotoxicity.

  1995cited by this paper
• Uptake of l‐Glutamate into Rat Brain Synaptic Vesicles: Effect of Inhibitors that Bind Specifically to the Glutamate Transporter

  1995cited by this paper
• The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor

  1994cited by this paper
• Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity.

  1993cited by this paper
• Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms.

  1991cited by this paper
• Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.

  1991cited by this paper
• Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta.

  1990cited by this paper

• A dual-action nanoparticle approach for spinal cord injury treatment: ferroptosis inhibition, inflammation control, and Myelin preservation

  2026cites this paper
• Central Nervous System Targeting Nanovesicles for Trans-Barrier Delivery and Spinal Cord Injury Treatment.

  2025cites this paper
• Acanthopagrus schlegelii FADD and caspase-8 are involved in the regulation of apoptosis and inflammation

  2025cites this paper
• Biomaterials for CNS disorders: a review of development from traditional methods to AI-assisted optimization

  2025cites this paper
• Green Synthesis, Chemical Characterization, and Assessment of the Neuroprotective Properties of Zinc Nanoparticles on the Spinal Cord Injury Contusive Model in Rats.

  2025cites this paper
• The drug delivery systems based on nanoparticles for spinal cord injury repair

  2025cites this paper
• Chicago Sky Blue 6B modulates MAPK/NF-kB pathway in rat knee osteoarthritis

  2025cites this paper
• Nanomedicine-enabled next-generation therapeutics for spinal cord injury

  2025cites this paper
• Exosome-shuttled miR-5121 from A2 astrocytes promotes BSCB repair after traumatic SCI by activating autophagy in vascular endothelial cells

  2025cites this paper
• NIR responsive microneedles patch used for promoting spinal cord injury repair by modulating mitochondrial ROS microenvironment

  2025cites this paper
• NLRP3 inflammasome promotes functional repair after spinal cord injury in mice by regulating autophagy and its mechanism.

  2025cites this paper
• C16 peptide and angiopoietin-1 alleviate the side effects of glucocorticoids in a rat multiple sclerosis model.

  2025cites this paper
• Multiphysics analysis of the dual role of magnetoelectric nanoparticles in a microvascular environment: from magnetic targeting to electrical activation

  2025cites this paper
• Solid phase synthesis of molecularly imprinted polymers for analytical and life science applications

  2025cites this paper
• The macrophage migration inhibitory factor/CD74 axis in traumatic spinal cord injury: lessons learned from animal and human studies

  2024cites this paper
• Functional biomaterials for modulating the dysfunctional pathological microenvironment of spinal cord injury

  2024cites this paper
• Nanoparticles for the treatment of spinal cord injury

  2024cites this paper
• Multifunctional Hierarchical Nanoplatform with Anisotropic Bimodal Mesopores for Effective Neural Circuit Reconstruction after Spinal Cord Injury.

  2024cites this paper
• Nanomaterials for the treatment of spinal cord injury

  2024cites this paper
• The Translation of Nanomedicines in the Contexts of Spinal Cord Injury and Repair

  2024cites this paper
• Carrier-Free Nanodrug Based on Co-Assembly of Methylprednisolone Dimer and Rutin for Combined Treatment of Spinal Cord Injury.

  2023cites this paper
• The Role of Nanotechnology in Spinal Cord Tumors.

  2023cites this paper
• Nanosystems-enabled regenerative strategies for spinal cord Injury: Recent advances and future prospects

  2023cites this paper
• Regulation of the JAK/STAT signaling pathway in spinal cord injury: an updated review

  2023cites this paper
• Hydrogel and Nanomedicine‐Based Multimodal Therapeutic Strategies for Spinal Cord Injury

  2023cites this paper
• Nanomaterial payload delivery to central nervous system glia for neural protection and repair

  2023cites this paper
• A comprehensive and updated review on the applications of vesicular drug delivery systems in treatment of brain disorders: A shelter against storms

  2023cites this paper
• Notoginsenoside R1 alleviates spinal cord injury through the miR-301a/KLF7 axis to activate Wnt/β-catenin pathway

  2022cites this paper
• Chicago sky blue 6B inhibits α-synuclein aggregation and propagation

  2022cites this paper
• Recent advances in nanomaterials for the treatment of spinal cord injury

  2022cites this paper
• Macrophage migration inhibitory factor facilitates astrocytic production of the CCL2 chemokine following spinal cord injury

  2022cites this paper
• Advanced Therapies for Traumatic Central Nervous System Injury: Delivery Strategy Reinforced Efficient Microglial Manipulation.

  2022cites this paper
• The protective effects of nesfatin‐1 in neurological dysfunction after spinal cord injury by inhibiting neuroinflammation

  2022cites this paper
• Is Graphene Shortening the Path toward Spinal Cord Regeneration?

  2022cites this paper
• Mechanism of inhibition of bacterial RNA helicases by diazo dyes and implications for antimicrobial drug development.

  2022cites this paper
• Highly bioactive iridium metal-complex alleviates spinal cord injury via ROS scavenging and inflammation reduction.

  2022cites this paper
• Overexpression of miR-338-5p in exosomes derived from mesenchymal stromal cells provides neuroprotective effects by the Cnr1/Rap1/Akt pathway after spinal cord injury in rats.

  2021cites this paper
• Macrophage migration inhibitory factor as a therapeutic target after traumatic spinal cord injury: a systematic review

  2021cites this paper
• Immunomodulatory Layered Double Hydroxide Nanoparticles Enable Neurogenesis by Targeting Transforming Growth Factor-β Receptor 2.

  2021cites this paper
• Nanopharmaceutical-based regenerative medicine: a promising therapeutic strategy for spinal cord injury.

  2021cites this paper
• Nanoparticle-Based Delivery to Treat Spinal Cord Injury—a Mini-review

  2021cites this paper
• Knockdown of lncRNA SNHG14 alleviates LPS-induced inflammation and apoptosis of PC12 cells by regulating miR-181b-5p

  2021cites this paper
• The design criteria and therapeutic strategy of functional scaffolds for spinal cord injury repair.

  2021cites this paper
• Recent Advances in the Application of Two-Dimensional Nanomaterials for Neural Tissue Engineering and Regeneration.

  2021cites this paper
• Upregulation of miR-128 inhibits neuronal cell apoptosis following spinal cord injury via FasL downregulation by repressing ULK1

  2021cites this paper
• Weighted gene co-expression network analysis reveals that CXCL10, IRF7, MX1, RSAD2, and STAT1 are related to the chronic stage of spinal cord injury

  2021cites this paper
• Targeted drug delivery systems to control neuroinflammation in central nervous system disorders

  2021cites this paper
• Chicago Sky Blue diazo-dye release from poly(methyl methacrylate) (PMMA) electrospun nanofibers

  2021cites this paper
• Advances in Biomaterial‐Based Spinal Cord Injury Repair

  2021cites this paper
• Advanced approaches to regenerate spinal cord injury: The development of cell and tissue engineering therapy and combinational treatments.

  2021cites this paper
• Biomaterial and Therapeutic Approaches for the Manipulation of Macrophage Phenotype in Peripheral and Central Nerve Repair

  2021cites this paper
• Tumor-associated macrophages in lung carcinoma: From mechanism to therapy.

  2021cites this paper
• Pharmacological therapies and factors delivery for spinal cord injury regeneration

  2020cites this paper
• Cellular and molecular imaging for stem cell tracking in neurological diseases

  2020cites this paper
• Scar Tissue-Targeting Polymer Micelle for Spinal Cord Injury Treatment.

  2020cites this paper
• A multi-effective and long-acting immunotherapy through one single hydrogel based injection.

  2020cites this paper
• Diffusion tensor imaging predicting neurological repair of spinal cord injury with transplanting collagen/chitosan scaffold binding bFGF

  2019cites this paper
• Polysialic-Acid-Based Micelles Promote Neural Regeneration in Spinal Cord Injury Therapy.

  2019cites this paper
• Biomaterials and glia: Progress on designs to modulate neuroinflammation.

  2019cites this paper
• Recent advances in nanotherapeutic strategies for spinal cord injury repair.

  2019cites this paper
• Nanoengineered biomaterials for spinal cord regeneration

  2019cites this paper
• Molybdenum disulfide nanoflowers mediated anti-inflammation macrophage modulation for spinal cord injury treatment.

  2019cites this paper
• Changes in neurological and pathological outcomes in a modified rat spinal cord injury model with closed canal

  2019cites this paper
• Suppression of LINC00707 alleviates lipopolysaccharide-induced inflammation and apoptosis in PC-12 cells by regulated miR-30a-5p/Neurod 1

  2019cites this paper
• Association between plasma macrophage migration inhibitor factor and deep vein thrombosis in patients with spinal cord injuries

  2019cites this paper
• Synthesis and Characterization of a Silica-Based Drug Delivery System for Spinal Cord Injury Therapy

  2019cites this paper
• How can nanovectors be used to treat spinal cord injury?

  2019cites this paper
• Macrophage migration inhibitory factor and its binding partner HTRA1 are expressed by olfactory ensheathing cells

  2019cites this paper
• The small molecule Chicago Sky Blue promotes heart repair following myocardial infarction in mice.

  2019cites this paper
• Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach

  2018cites this paper
• Se@SiO2 nanocomposites suppress microglia-mediated reactive oxygen species during spinal cord injury in rats

  2018cites this paper
• Engineering Controlled Peritumoral Inflammation to Constrain Brain Tumor Growth

  2018cites this paper
• Spinal Cord Injury Scarring and Inflammation: Therapies Targeting Glial and Inflammatory Responses

  2018cites this paper
• A chitosan scaffold infused with neurotrophin-3 and human umbilical cord mesenchymal stem cells suppresses inflammation and promotes functional recovery after spinal cord injury in mice

  2017cites this paper
• Chemoselective functionalization of nanogels for microglia treatment

  2017cites this paper
• Magnetic resonance imaging tracking and assessing repair function of the bone marrow mesenchymal stem cells transplantation in a rat model of spinal cord injury

  2017cites this paper
• Effective improvement of the neuroprotective activity after spinal cord injury by synergistic effect of glucocorticoid with biodegradable amphipathic nanomicelles

  2017cites this paper
• Discovery of antimicrobial compounds targeting bacterial type FAD synthetases

  2017cites this paper
• Nanofiber Scaffolds as Drug Delivery Systems to Bridge Spinal Cord Injury

  2017cites this paper
• Biomaterial strategies for limiting the impact of secondary events following spinal cord injury

  2017cites this paper
• Pharmacological Tools to Activate Microglia and their Possible use to Study Neural Network Patho-physiology

  2017cites this paper
• CHRONIC INTRACORTICAL ELECTRODES: MODULATION OF THE BLOOD-BRAIN BARRIER AND THE FUNCTIONAL IMPLICATIONS

  2017cites this paper
• Graft of the NT-3 persistent delivery gelatin sponge scaffold promotes axon regeneration, attenuates inflammation, and induces cell migration in rat and canine with spinal cord injury.

  2016cites this paper
• Endosomal pH modulation by peptide-gold nanoparticle hybrids enables potent anti-inflammatory activity in phagocytic immune cells.

  2016cites this paper
• Nanoparticle Technologies in the Spinal Cord

  2016cites this paper
• Methylprednisolone promotes recovery of neurological function after spinal cord injury: association with Wnt/β-catenin signaling pathway activation

  2016cites this paper
• Early modulation of pro-inflammatory microglia by minocycline loaded nanoparticles confers long lasting protection after spinal cord injury.

  2016cites this paper
• Nanotherapeutics of PTEN Inhibitor with Mesoporous Silica Nanocarrier Effective for Axonal Outgrowth of Adult Neurons.

  2016cites this paper
• Targeting specific cells in the brain with nanomedicines for CNS therapies.

  2016influential citation
• The change tendency of PI 3 K / Akt pathway after spinal cord injury

  2015cites this paper
• Impact of Mechanotransduction in the Context of Central Nervous System Diseases

  2015cites this paper
• A critical evaluation of drug delivery from ligand modified nanoparticles: Confounding small molecule distribution and efficacy in the central nervous system.

  2015cites this paper
• Biomaterial Approaches to Enhancing Neurorestoration after Spinal Cord Injury: Strategies for Overcoming Inherent Biological Obstacles

  2015cites this paper
• The change tendency of PI3K/Akt pathway after spinal cord injury.

  2015cites this paper
• Drug delivery, cell-based therapies, and tissue engineering approaches for spinal cord injury.

  2015cites this paper
• Controlled release strategies for modulating immune responses to promote tissue regeneration.

  2015cites this paper